Suzhou Fushilai Pharmaceutical Co., Ltd. (SHE:301258)
China · Delayed Price · Currency is CNY 37.28
+0.37 (1.00%)
Jan 20, 2026, 4:00 PM EST
Revenue by Product
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
Lipoic Acid Series | 276.48M | Log In | Log In | Log In | Log In | Upgrade |
Lipoic Acid Series Growth | -26.25% | Log In | Log In | Log In | Log In | Upgrade |
Irecoxib | 62.98M | Log In | Log In | Log In | Log In | Upgrade |
Irecoxib Growth | 835.06% | Log In | Log In | Log In | Log In | Upgrade |
Carnosine Series | 45.45M | Log In | Log In | Log In | Log In | Upgrade |
Carnosine Series Growth | -24.09% | Log In | Log In | Log In | Log In | Upgrade |
Phosphatidylcholine Series | 41.09M | Log In | Log In | Log In | Log In | Upgrade |
Phosphatidylcholine Series Growth | -1.26% | Log In | Log In | Log In | Log In | Upgrade |
Other Business | 3.46M | Log In | Log In | Log In | Log In | Upgrade |
Other Business Growth | -44.10% | Log In | Log In | Log In | Log In | Upgrade |
Granular Lipoic Acid | - | Log In | Log In | Log In | Log In | Upgrade |
Granular Lipoic Acid Growth | - | Log In | Log In | Log In | Log In | Upgrade |
GPC - Liquid | - | Log In | Log In | Log In | Log In | Upgrade |
GPC - Liquid Growth | - | Log In | Log In | Log In | Log In | Upgrade |
L-Carnosine | - | Log In | Log In | Log In | Log In | Upgrade |
L-Carnosine Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Ethyl Dichlorooctanoate | - | Log In | Log In | Log In | Log In | Upgrade |
Ethyl Dichlorooctanoate Growth | - | Log In | Log In | Log In | Log In | Upgrade |
High Purity Solvent-free Lipoic Acid | - | Log In | Log In | Log In | Log In | Upgrade |
High Purity Solvent-free Lipoic Acid Growth | - | Log In | Log In | Log In | Log In | Upgrade |
R-Lipoic Acid Tromethamine | - | Log In | Log In | Log In | Log In | Upgrade |
R-Lipoic Acid Tromethamine Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Others - Lipoic Acid Series | - | Log In | Log In | Log In | Log In | Upgrade |
Others - Lipoic Acid Series Growth | - | Log In | Log In | Log In | Log In | Upgrade |
R-Lipoic Acid | - | Log In | Log In | Log In | Log In | Upgrade |
R-Lipoic Acid Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other | - | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
China | 218.24M | Log In | Log In | Log In | Log In | Upgrade |
China Growth | 20.31% | Log In | Log In | Log In | Log In | Upgrade |
Foreign | 211.23M | Log In | Log In | Log In | Log In | Upgrade |
Foreign Growth | -31.39% | Log In | Log In | Log In | Log In | Upgrade |
Asia | - | Log In | Log In | Log In | Log In | Upgrade |
Asia Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Europe | - | Log In | Log In | Log In | Log In | Upgrade |
Europe Growth | - | Log In | Log In | Log In | Log In | Upgrade |
America | - | Log In | Log In | Log In | Log In | Upgrade |
America Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Africa | - | Log In | Log In | Log In | Log In | Upgrade |
Africa Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Oceania | - | Log In | Log In | Log In | Log In | Upgrade |
Oceania Growth | - | Log In | Log In | Log In | Log In | Upgrade |